focus
Previous article:
Drug repurposing or repositioning? The language matters
Next article: Novo Holdings to buy drug manufacturer Catalent in $16.5B deal
Next article: Novo Holdings to buy drug manufacturer Catalent in $16.5B deal
entertainment
focus
-
The Biogen Aduhelm mess could happen again
2025-10-02 10:30 -
Why Novartis is going to walk from its acquisition of MorphoSys
2025-10-02 09:53 -
Washington mulls new rules to avert another Change Healthcare
2025-10-02 09:53 -
Supreme Court mifepristone arguments center on docs' right to sue
2025-10-02 09:39 -
Covid vaccine financial winners and losers, from Pfizer to Novavax
2025-10-02 09:15 -
Padmanee Sharma of MD Anderson at center of lawsuit over credit
2025-10-02 08:45